Walgreens Boots Alliance, Inc.

Equities

WBA

US9314271084

Drug Retailers

Market Closed - Nasdaq 21:00:00 24/06/2024 BST 5-day change 1st Jan Change
15.91 USD -0.38% Intraday chart for Walgreens Boots Alliance, Inc. +5.02% -39.07%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Equity Markets Close Mixed as Investors Await Key Earnings MT
Equity Markets Close Mixed as Investors Await Week's Key Earnings MT
US Equities Markets End Mixed Monday as Traders Await Key Corporate Earnings MT
Equity Markets Mixed as Investors Await Week's Key Earnings MT
Walgreens Boots Alliance Fiscal Q3 Unlikely to Impact Stock, UBS Says MT
Equity Markets Mixed as Investors Await Week's Key Earnings MT
UBS Cuts Price Target on Walgreens Boots Alliance to $17 From $22, Maintains Neutral Rating MT
Key week for monetary policy Our Logo
Futures Mostly Up Pre-Bell as Investors Prepare for Key Inflation Report; Asia Down, Europe Rises MT
Barclays Adjusts Price Target on Walgreens Boots Alliance to $15 From $21 MT
ANALYST RECOMMENDATIONS : Accenture, Walgreens Boots Alliance, Ge Vernova, Pepsico, Britvic... Our Logo
Amazon Pharmacy expands $5 monthly subscription to Medicare patients RE
CVS Store-Brand Medications Face Quality Concerns and Higher Recall Rates MT
Global markets live: ABB, Roche, Microsoft, Apple, Tesla... Our Logo
Walgreens Reportedly Shelves Plans for Boots IPO as Sale Talks Continue CI
Top law firms in US opioid lawsuits to get hundreds of millions in fees RE
CityMD Agrees to $12 Million to Pay Department of Justice Over Alleged Covid-19 Payments Violation DJ
CityMD Agrees to $12 Million to Pay Department of Justice Over Alleged Covid-19 Payments Violation -- Update DJ
Sector Update: Health Care Stocks Higher Late Afternoon MT
Sector Update: Health Care MT
Walgreens Shelves Boots IPO Plans, Explores Other Options MT
Walgreens Shelves Boots IPO Plans, Explores Other Options MT
Walgreens shelves plans for Boots IPO, Bloomberg News reports RE
Walgreens to Shelve Boots IPO Plans as Sale Talks Continue, Bloomberg Says MT
Leerink Adjusts Price Target on Walgreens Boots Alliance to $17 From $22 MT
Chart Walgreens Boots Alliance, Inc.
More charts
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
15.91 USD
Average target price
21.52 USD
Spread / Average Target
+35.26%
Consensus
  1. Stock Market
  2. Equities
  3. WBA Stock
  4. News Walgreens Boots Alliance, Inc.
  5. Sector Update: Health Care Stocks Lower Thursday Afternoon